Effects of Insole Vibration With Proprioceptive Training in Patients With Diabetic Peripheral Neuropathy

August 18, 2025 updated by: Riphah International University

Effects of Insole Vibration With Proprioceptive Training on Balance and Functional Ability in Patients With Diabetic Peripheral Nuropathy

Diabetic peripheral neuropathy (DPN) is a prevalent complication of diabetes, profoundly affecting quality of life with sensory disturbances and associated complications. Proprioceptive training shows promise in improving proprioception and functional outcomes in patients with peripheral neuropathy. Also the literature has shown that Insole vibrator demonstrates potential in mitigating symptoms and improving sensory function and balance in patients with peripheral neuropathy. This study aims to determine the effects of insole vibration with proprioceptive training on balance and functional ability in patient with diabetic peripheral neuropathy.

In this randomized controlled trial design, 60 participants will be recruited. The sample size was calculated through G-power total of 60 participants. Who meet the inclusion criteria will be recruited through non-probability convenience sampling technique, which will further be randomized through online randomizer tool into control and experimental group with thirty participants in each group. Experimental group will receive proprioceptive training alongside vibrating insole and control group will receive proprioceptive training with non vibrating insoles. Data will be collected by using various assessment tools, including Numeric Pain Rating Scale for pain,Time Up And Go Test for functional mobility, Neuropathic Disability Score for level of disability ,Functional Reach Test for standing stability, Mini BESTS for balance, functional mobility and gait, Single Leg Stance Test for static posture and balance control and the Montreal Cognitive Assessment for cognitive impairment. Pre-intervention assessments will be conducted for both groups. The effects of the interventions will be measured at pre-treatment, 6th week, 12th week and at 16th week. Data analysis will be performed by using SPSS 26. Mixed ANOVA and repeated-measures ANOVA will use for within-group analysis whereas between-group analysis will perform by using one-way ANOVA.

Key words: Diabetic polyneuropathy, Vibrating insole, proprioceptive training, balance

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Faisalābad, Pakistan, 54660
        • Chiniot General Hospital and Civil Hospital (Allied 2), Faisalabad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • • Patients with both genders male and female will be included

    • The age limit for the patients will be from 50 to 70 years
    • Patients diagnosed with DPN type 1 or type 2
    • Patients with neuropathic disability score greater than 3 will be included
    • Patients with Michigan questionnaire higher than 3
    • Patients who can walk independently with BBS score between 41 to 56

Exclusion Criteria:

  • Patients with Mini Mental State less than 24
  • Patients having Numeric Pain Rating Scale greater than 4
  • Patients with any impairment in lower leg e.g; Leg Length Discrepancy, foot ulcer, lower limb injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Participants in this arm will perform both proprioceptive training exercises and receive insole vibrator.
The treatment for the participants in the experimental group includes; 5 minutes warm up, 30 minutes proprioceptive training exercise, 20 minutes walk with in-sole vibrator, 5 minutes cool down. The duration of each session will be 60 minutes. All the participants will receive 36 sessions (3 times per week over 12 week's period).
Active Comparator: Group B
Participants in this arm will receive only proprioceptive training exercise along with simple insoles without vibration.
The treatment for the participants in the control group includes; 5 minutes warm up, 30 minutes proprioceptive training exercise, 20 minutes walk with non-vibrating insole, 5 minutes cool down. The duration of each session will be 60 minutes. All the participants will receive 36 sessions (3 times per week over 12 week's period).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale (NPRS)
Time Frame: Baseline after completion of 6 and 8 weeks
to measure pain scale range 0-10. zero means no pain 10 means maximum
Baseline after completion of 6 and 8 weeks
Time Up and Go (TUG) Test
Time Frame: Baseline after completion of 6 and 8 weeks
To measure mobility and fall risk (time to rise, walk, return) measure in seconds time > 20 sec means impaired mobility
Baseline after completion of 6 and 8 weeks
Neuropathic Disability score (NDS)
Time Frame: Baseline after completion of 6 and 8 weeks
Severity of PND (0-10 scale) 0 means no disability 10 means maximum disability
Baseline after completion of 6 and 8 weeks
Functional Reach test (FRT)
Time Frame: Baseline after completion of 6 and 8 weeks
to measure anticipatory postural control Stability and fall risk
Baseline after completion of 6 and 8 weeks
Mini-BESTest
Time Frame: Baseline after completion of 6 and 8 weeks
to measure static and dynamic balance (0-30 scale) greater score means better mobility
Baseline after completion of 6 and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aruba Saeed, PhD, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2025

Primary Completion (Actual)

August 15, 2025

Study Completion (Actual)

August 15, 2025

Study Registration Dates

First Submitted

April 17, 2025

First Submitted That Met QC Criteria

August 18, 2025

First Posted (Actual)

August 19, 2025

Study Record Updates

Last Update Posted (Actual)

August 19, 2025

Last Update Submitted That Met QC Criteria

August 18, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetic Peripheral Neuropathy (DPN)

Clinical Trials on proprioceptive training exercise and receive insole vibrator

Subscribe